This is in accordance with previous studies in two different transgenic mouse models where it has been shown that a reduction in plasma membrane sphingomyelins improves insulin sensitivity and ameliorates high‐fat induced obesity (Li et al, 2011). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.